enVVeno Medical SG&A Expense (TTM) Analysis

enVVeno Medical Corp (NVNO)

3.19 0.00 (0.00%) USD | NASDAQ | Oct 04, 16:00

3.19 0.00 (0.00%) After-Hours: 18:18

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2017. Upgrade now.

Date	Value
June 30, 2024	10.93M
March 31, 2024	10.90M
December 31, 2023	11.65M
September 30, 2023	12.02M
June 30, 2023	13.12M
March 31, 2023	14.44M
December 31, 2022	15.02M
September 30, 2022	18.57M
June 30, 2022	16.39M
March 31, 2022	13.77M
December 31, 2021	11.16M
September 30, 2021	5.835M
June 30, 2021	5.517M
March 31, 2021	5.061M
December 31, 2020	4.883M

Date	Value
September 30, 2020	3.924M
June 30, 2020	3.917M
March 31, 2020	4.609M
December 31, 2019	4.912M
September 30, 2019	5.206M
June 30, 2019	5.153M
March 31, 2019	6.536M
December 31, 2018	6.483M
September 30, 2018	6.923M
June 30, 2018	7.482M
March 31, 2018	5.653M
December 31, 2017	5.456M
September 30, 2017	5.028M
June 30, 2017	4.322M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

3.917M

Minimum

Jun 2020

18.57M

Maximum

Sep 2022

9.822M

Average

10.93M

Median

Jun 2024

SG&A Expense (TTM) Benchmarks